Document Type : Original Article
Authors
1 Department of cell and molecular biology,Faculty of biological sciences, Kharazmi university, Tehran, Iran
2 National Institute of Genetic Engineering and Biotechnology.
Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune. Early diagnosis of RA remains challenging. A significant portion of RA patients also experience unremitting symptoms despite treatment. miRNA are involved in the regulation of autoimmunity- and inflammation-related processes. In this study, we evaluated the expression of miR-22-3p in serum of RA patients as a novel biomarker. Expression level of this gene in the blood serum of 30 people with RA compared with 30 healthy individuals by the qRT-PCR method. Results showed levels of miR22-3p were significantly higher in the serum of patients with RA in comparison with healthy control (p<0.0001). We suggest that miR 22-3p can be used as a biomarker in early detection and screening.
Keywords
2.Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmunity reviews. 2005 Mar 1;4(3):130-6.
3.Alpizar-Rodriguez D, Lesker TR, Gronow A, Gilbert B, Raemy E, Lamacchia C, Gabay C, Finckh A, Strowig T. Prevotella copri in individuals at risk for rheumatoid arthritis. Annals of the rheumatic diseases. 2019 May 1;78(5):590-3.
4.Cunningham CC, Wade S, Floudas A, Orr C, McGarry T, Wade S, Cregan S, Fearon U, Veale DJ. Serum miRNA signature in rheumatoid arthritis and “at-risk individuals”. Frontiers in immunology. 2021 Mar 3;12:126.
5.O’Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Frontiers in endocrinology. 2018 Aug 3;9:402.
6.Vasudevan S. Posttranscriptional upregulation by microRNAs. Wiley Interdisciplinary Reviews: RNA. 2012 May;3(3):311-30.
7.Bogunia-Kubik K, Wysoczańska B, Piątek D, Iwaszko M, Ciechomska M, Świerkot J. Significance of polymorphism and expression of miR-146a and NFkB1 genetic variants in patients with rheumatoid arthritis. Archivum immunologiae et therapiae experimentalis. 2016 Dec;64(1):131-6.
8.Liu F, Liang Y, Zhao Y, Chen L, Wang X, Zhang C. Meta-analysis of association of microRNAs genetic variants with susceptibility to rheumatoid arthritis and systemic lupus erythematosus. Medicine. 2021 Apr 30;100(17).
9.Hussein NA, Kholy ZA, Anwar MM, Ahmad MA, Ahmad SM. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer. Journal of cancer research and clinical oncology. 2017 Jan;143(1):83-93.
10.Pandey AK, Zhang Y, Zhang S, Li Y, Tucker-Kellogg G, Yang H, Jha S. TIP60-miR-22 axis as a prognostic marker of breast cancer progression. Oncotarget. 2015 Dec 1;6(38):41290.
11.Ahmad HM, Muiwo P, Ramachandran SS, Pandey P, Gupta YK, Kumar L, Kulshreshtha R, Bhattacharya A. miR‐22 regulates expression of oncogenic neuro‐epithelial transforming gene 1, NET 1. The FEBS Journal. 2014 Sep;281(17):3904-19.
12.Yang C, Ning S, Li Z, Qin X, Xu W. miR-22 is down-regulated in esophageal squamous cell carcinoma and inhibits cell migration and invasion. Cancer cell international. 2014 Dec;14(1):1-6.
13.Wang X, Yu H, Lu X, Zhang P, Wang M, Hu Y. MiR-22 suppresses the proliferation and invasion of gastric cancer cells by inhibiting CD151. Biochemical and biophysical research communications. 2014 Feb 28;445(1):175-9.
14.Evangelatos G, Fragoulis GE, Koulouri V, Lambrou GI. MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact. Autoimmunity Reviews. 2019 Nov 1;18(11):102391.
15.Lin J, Huo R, Xiao L, Zhu X, Xie J, Sun S, He Y, Zhang J, Sun Y, Zhou Z, Wu P. A novel p53/microRNA‐22/Cyr61 axis in synovial cells regulates inflammation in the rheumatoid arthritis. Arthritis & rheumatology. 2014 Jan;66(1):49-59.
16.Butola LK, Anjanker A, Vagga A, Kaple MN. Endogenous factor and pathophysiology of rheumatoid arthritis: an autoimmune disease from decades. Int J Cur Res Rev. 2020 Nov;12(22):34-40.
17.Wang D, Li Y, Liu Y, Shi G. The role of autoreactive T cell in the pathogenesis of rheumatoid arthritis and implications for T cell targetedvaccine therapy. Minerva Med. 2015;106:157-167.
18.Zhang X, Singla S, Pound J, et al. Identification of follicular helper Tcells as a novel cell population potentially involved in the pathogenesis of Rheumatoid Arthritis. J Immunol. 2015;194:121.
19.Aune TM, Crooke PS, Patrick AE, Tossberg JT, Olsen NJ, Spurlock CF. Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants. J Autoimmun. 2017;81:99-109.
20.Zhang F, Gao C, Ma XF, et al. Expression profile of long noncoding RNAs in peripheral blood mononuclear cells from multiple sclerosis patients. CNS Neurosci Ther. 2016;22:298-305.
21.Wu GC, Pan HF, Leng RX, et al. Emerging role of long noncoding RNAs in autoimmune diseases. Autoimmun Rev. 2015;14:798-805.
22.Kaur S, Mirza AH, Brorsson CA, et al. The genetic and regulatory architecture of ERBB3-type I diabetes susceptibility locus. Mol Cell Endocrinol. 2016;419:83-91.
)